Pulmonary veno-occlusive disease: Recent progress and current challenges

Respiratory Medicine

Volumn 104, Issue SUPPL. 1, 2010, Pages

  Montani, David ^a   O'Callaghan, Dermot S ^a   Savale, Laurent ^a   Jaïs, Xavier ^a   Yaïci, Azzedine ^a   Maitre, Sophie ^a   Dorfmuller, Peter ^a   Sitbon, Olivier ^a   Simonneau, Gérald ^a   Humbert, Marc ^a  

^a UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

Alveolar haemorrhage; BMPR2; Carbon monoxide diffusing capacity; Computed tomography; Pulmonary arterial hypertension; Pulmonary veno occlusive disease

Indexed keywords

BONE MORPHOGENETIC PROTEIN RECEPTOR 2; BOSENTAN; CALCIUM CHANNEL BLOCKING AGENT; CARBON MONOXIDE; DIURETIC AGENT; ILOPROST; IMMUNOSUPPRESSIVE AGENT; NITRIC OXIDE; PROSTACYCLIN; SILDENAFIL; VASODILATOR AGENT; WARFARIN;

ARTICLE; BRONCHOSCOPY; CAPILLARY PROLIFERATION; CLINICAL ASSESSMENT; DIFFERENTIAL DIAGNOSIS; DRUG DOSE TITRATION; DRUG MEGADOSE; FORCED EXPIRATORY VOLUME; GENE MUTATION; HEART CATHETERIZATION; HEART RIGHT VENTRICLE FAILURE; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HISTOPATHOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATORY DISEASE; LUNG ALVEOLUS OXYGEN TENSION; LUNG ARTERY PRESSURE; LUNG BIOPSY; LUNG CAPILLARY; LUNG DIFFUSION CAPACITY; LUNG EDEMA; LUNG FUNCTION TEST; LUNG LAVAGE; LUNG SCINTISCANNING; LUNG TRANSPLANTATION; LUNG VASCULAR RESISTANCE; LYMPH NODE; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; PULMONARY ARTERY; PULMONARY ARTERY OCCLUSION PRESSURE; PULMONARY CAPILLARY HEMANGIOMATOSIS; PULMONARY HYPERTENSION; PULMONARY VEIN; PULMONARY VENO-OCCLUSIVE DISEASE; PULMONARY VENULE; RISK FACTOR; SMOKING; SYMPTOM; THORAX RADIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY; VENULE;

EID: 77953263721     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2010.03.014     Document Type: Article

References (71)

1. Montani D., Achouh L., Dorfmuller P., et al. Pulmonary veno-occlusive disease: clinical, functional, radiologic, and hemodynamic characteristics and outcome of 24 cases confirmed by histology. Medicine (Baltimore) 87 4 (2008) 220-233
2. Simonneau G., Robbins I.M., Beghetti M., et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 54 1_Suppl_S (2009) S43-S54
3. Montani D., Price L.C., Dorfmuller P., et al. Pulmonary veno-occlusive disease. Eur Respir J 33 1 (2009) 189-200
4. Palmer S.M., Robinson L.J., Wang A., Gossage J.R., Bashore T., and Tapson V.F. Massive pulmonary edema and death after prostacyclin infusion in a patient with pulmonary veno-occlusive disease. Chest 113 1 (1998) 237-240
5. Mandel J., Mark E.J., and Hales C.A. Pulmonary veno-occlusive disease. Am J Respir Crit Care Med 162 5 (2000) 1964-1973
6. Hora J. Zur histologie der klinischen 'primaren pulmonalsklerose'. Frankf Z Pathol 47 (1934) 100
7. Heath D., Segel N., and Bishop J. Pulmonary veno-occlusive disease. Circulation 34 2 (1966) 242-248
8. Wagenvoort C.A. Lung biopsy specimens in the evaluation of pulmonary vascular disease. Chest 77 5 (1980) 614-625
9. Bjornsson J., and Edwards W.D. Primary pulmonary hypertension: a histopathologic study of 80 cases. Mayo Clin Proc 60 1 (1985) 16-25
10. Yi E.S., Kim H., Ahn H., et al. Distribution of obstructive intimal lesions and their cellular phenotypes in chronic pulmonary hypertension. A morphometric and immunohistochemical study. Am J Respir Crit Care Med 162 4 Pt 1 (2000) 1577-1586
11. Humbert M., Sitbon O., Chaouat A., et al. Pulmonary arterial hypertension in France: results from a national registry. Am J Respir Crit Care Med 173 9 (2006) 1023-1030
12. Bunte M.C., Patnaik M.M., Pritzker M.R., and Burns L.J. Pulmonary veno-occlusive disease following hematopoietic stem cell transplantation: a rare model of endothelial dysfunction. Bone Marrow Transplant 41 8 (2008) 677-686
13. Davies P., and Reid L. Pulmonary veno-occlusive disease in siblings: case reports and morphometric study. Hum Pathol 13 10 (1982) 911-915
14. Voordes C.G., Kuipers J.R., and Elema J.D. Familial pulmonary veno-occlusive disease: a case report. Thorax 32 6 (1977) 763-766
15. Thomson J.R., Machado R.D., Pauciulo M.W., et al. Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-beta family. J Med Genet 37 10 (2000) 741-745
16. Atkinson C., Stewart S., Upton P.D., et al. Primary pulmonary hypertension is associated with reduced pulmonary vascular expression of type II bone morphogenetic protein receptor. Circulation 105 14 (2002) 1672-1678
17. Sztrymf B., Coulet F., Girerd B., et al. Clinical outcomes of pulmonary arterial hypertension in carriers of BMPR2 mutation. Am J Respir Crit Care Med 177 12 (2008) 1377-1383
18. Runo J.R., Vnencak-Jones C.L., Prince M., et al. Pulmonary veno-occlusive disease caused by an inherited mutation in bone morphogenetic protein receptor II. Am J Respir Crit Care Med 167 6 (2003) 889-894
19. Aldred M.A., Vijayakrishnan J., James V., et al. BMPR2 gene rearrangements account for a significant proportion of mutations in familial and idiopathic pulmonary arterial hypertension. Hum Mutat 27 2 (2006) 212-213
20. Machado R.D., Aldred M.A., James V., et al. Mutations of the TGF-beta type II receptor BMPR2 in pulmonary arterial hypertension. Hum Mutat 27 2 (2006) 121-132
21. Galie N., Torbicki A., Barst R., et al. Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The task force on diagnosis and treatment of pulmonary arterial hypertension of the European society of cardiology. Eur Heart J 25 24 (2004) 2243-2278
22. Gagnadoux F., Capron F., and Lebeau B. Pulmonary veno-occlusive disease after neoadjuvant mitomycin chemotherapy and surgery for lung carcinoma. Lung Cancer 36 2 (2002) 213-215
23. Shahab N., Haider S., and Doll D.C. Vascular toxicity of antineoplastic agents. Semin Oncol 33 1 (2006) 121-138
24. Mukai M., Kondo M., Bohgaki T., Notoya A., and Kohno M. Pulmonary veno-occlusive disease following allogeneic peripheral blood stem cell transplantation for chronic myeloid leukaemia. Br J Haematol 123 1 (2003) 1
25. Swift G.L., Gibbs A., Campbell I.A., Wagenvoort C.A., and Tuthill D. Pulmonary veno-occlusive disease and Hodgkin's lymphoma. Eur Respir J 6 4 (1993) 596-598
26. Ibrahim N.B., Burnley H., Gaber K.A., et al. Segmental pulmonary veno-occlusive disease secondary to lung cancer. J Clin Pathol 58 4 (2005) 434-436
27. Trobaugh-Lotrario A.D., Greffe B., Deterding R., Deutsch G., and Quinones R. Pulmonary veno-occlusive disease after autologous bone marrow transplant in a child with stage IV neuroblastoma: case report and literature review. J Pediatr Hematol Oncol 25 5 (2003) 405-409
28. Seguchi M., Hirabayashi N., Fujii Y., et al. Pulmonary hypertension associated with pulmonary occlusive vasculopathy after allogeneic bone marrow transplantation. Transplantation 69 1 (2000) 177-179
29. Salzman D., Adkins D.R., Craig F., Freytes C., and LeMaistre C.F. Malignancy-associated pulmonary veno-occlusive disease: report of a case following autologous bone marrow transplantation and review. Bone Marrow Transplant 18 4 (1996) 755-760
30. Canny G.J., Arbus G.S., Wilson G.J., and Newth C.J. Fatal pulmonary hypertension following renal transplantation. Br J Dis Chest 79 2 (1985) 191-195
31. Rabiller A., Jais X., Hamid A., et al. Occult alveolar haemorrhage in pulmonary veno-occlusive disease. Eur Respir J 27 1 (2006) 108-113
32. Wright J.L., Tai H., and Churg A. Cigarette smoke induces persisting increases of vasoactive mediators in pulmonary arteries. Am J Respir Cell Mol Biol 31 5 (2004) 501-509
33. Hoffstein V., Ranganathan N., and Mullen J.B. Sarcoidosis simulating pulmonary veno-occlusive disease. Am Rev Respir Dis 134 4 (1986) 809-811
34. Hamada K., Teramoto S., Narita N., Yamada E., Teramoto K., and Kobzik L. Pulmonary veno-occlusive disease in pulmonary Langerhans' cell granulomatosis. Eur Respir J 15 2 (2000) 421-423
35. Hasleton P.S., Ironside J.W., Whittaker J.S., Kelly W., Ward C., and Thompson G.S. Pulmonary veno-occlusive disease. A report of four cases. Histopathology 10 9 (1986) 933-944
36. Kokturk N., Demir N., Demircan S., et al. Pulmonary veno-occlusive disease in a patient with a history of Hashimoto's thyroiditis. Indian J Chest Dis Allied Sci 47 4 (2005) 289-292
37. Dorfmuller P., Humbert M., Perros F., et al. Fibrous remodeling of the pulmonary venous system in pulmonary arterial hypertension associated with connective tissue diseases. Hum Pathol 38 6 (2007) 893-902
38. Johnson S.R., Patsios D., Hwang D.M., and Granton J.T. Pulmonary veno-occlusive disease and scleroderma associated pulmonary hypertension. J Rheumatol 33 11 (2006) 2347-2350
39. Morassut P.A., Walley V.M., and Smith C.D. Pulmonary veno-occlusive disease and the CREST variant of scleroderma. Can J Cardiol 8 10 (1992) 1055-1058
40. Dorfmuller P., Montani D., and Humbert M. A walk on the far side of the lung - pulmonary venous involvement in patients suffering from systemic sclerosis-associated pulmonary arterial hypertension. Eur Respir J 35 1 (2010) 6-8
41. Zhang L., Visscher D., Rihal C., and Aubry M.C. Pulmonary veno-occlusive disease as a primary cause of pulmonary hypertension in a patient with mixed connective tissue disease. Rheumatol Int 27 12 (2007) 1163-1165
42. Lantuejoul S., Sheppard M.N., Corrin B., Burke M.M., and Nicholson A.G. Pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis: a clinicopathologic study of 35 cases. Am J Surg Pathol 30 7 (2006) 850-857
43. Stewart S., and Rassl D. Advances in the understanding and classification of pulmonary hypertension. Histopathology 54 1 (2009) 104-116
44. Frazier A.A., Franks T.J., Cooke E.O., Mohammed T.L., Pugatch R.D., and Galvin J.R. From the archives of the AFIP: pulmonary alveolar proteinosis. Radiographics 28 3 (2008) 883-899 quiz 915
45. de Montpreville V., Dulmet E., Fadel E., and Dartevelle P. Lymph node pathology in pulmonary veno-occlusive disease and pulmonary capillary heamangiomatosis. Virchows Arch 453 2 (2008) 171-176
46. Wagenvoort C.A., and Wagenvoort N. The pathology of pulmonary veno-occlusive disease. Virchows Arch A Pathol Anat Histol 364 1 (1974) 69-79
47. McGoon M., Gutterman D., Steen V., et al. Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 126 1 Suppl (2004) 14S-34S
48. McLaughlin V.V., Archer S.L., Badesch D.B., et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American college of cardiology foundation task force on expert consensus documents and the american heart association developed in collaboration with the american college of chest physicians; American Thoracic Society, Inc.; and the Pulmonary hypertension association. J Am Coll Cardiol 53 17 (2009) 1573-1619
49. Rubin L.J. Diagnosis and management of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 126 1 Suppl (2004) 7S-10S
50. Sitbon O., Humbert M., Jais X., et al. Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension. Circulation 111 23 (2005) 3105-3111
51. Holcomb Jr. B.W., Loyd J.E., Ely E.W., Johnson J., and Robbins I.M. Pulmonary veno-occlusive disease: a case series and new observations. Chest 118 6 (2000) 1671-1679
52. Scheibel R.L., Dedeker K.L., Gleason D.F., Pliego M., and Kieffer S.A. Radiographic and angiographic characteristics of pulmonary veno-occlusive disease. Radiology 103 1 (1972) 47-51
53. Resten A., Maitre S., Humbert M., et al. Pulmonary hypertension: CT of the chest in pulmonary venoocclusive disease. AJR Am J Roentgenol 183 1 (2004) 65-70
54. Resten A., Maitre S., Humbert M., et al. Pulmonary arterial hypertension: thin-section CT predictors of epoprostenol therapy failure. Radiology 222 3 (2002) 782-788
55. Rich S., Pietra G.G., Kieras K., Hart K., and Brundage B.H. Primary pulmonary hypertension: radiographic and scintigraphic patterns of histologic subtypes. Ann Intern Med 105 4 (1986) 499-502
56. Bailey C.L., Channick R.N., Auger W.R., et al. "High probability" perfusion lung scans in pulmonary venoocclusive disease. Am J Respir Crit Care Med 162 5 (2000) 1974-1978
57. Alam S., and Palevsky H.I. Standard therapies for pulmonary arterial hypertension. Clin Chest Med 28 1 (2007) 91-115 viii
58. Montani D., Jais X., Price L.C., et al. Cautious use of epoprostenol therapy is a safe bridge to lung transplantation in pulmonary veno-occlusive disease. Eur Respir J 34 6 (2009) 1348-1356
59. Barst R.J., Rubin L.J., Long W.A., et al. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. The primary pulmonary hypertension study group. N Engl J Med 334 5 (1996) 296-302
60. Badesch D.B., Tapson V.F., McGoon M.D., et al. Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial. Ann Intern Med 132 6 (2000) 425-434
61. Barboza C.E., Jardim C.V., Hovnanian A.L., Dias B.A., and Souza R. Pulmonary veno-occlusive disease: diagnostic and therapeutic alternatives. J Bras Pneumol 34 9 (2008) 749-752
62. Barreto A.C., Franchi S.M., Castro C.R., and Lopes A.A. One-year follow-up of the effects of sildenafil on pulmonary arterial hypertension and veno-occlusive disease. Braz J Med Biol Res 38 2 (2005) 185-195
63. Creagh-Brown B.C., Nicholson A.G., Showkathali R., Gibbs J.S., and Howard L.S. Pulmonary veno-occlusive disease presenting with recurrent pulmonary oedema and the use of nitric oxide to predict response to sildenafil. Thorax 63 10 (2008) 933-934
64. Montani D., Jais X., Dorfmuller P., Simonneau G., Sitbon O., and Humbert M. Goal-oriented therapy in pulmonary veno-occlusive disease: a word of caution. Eur Respir J 34 5 (2009) 1204-1206
65. Hoeper M.M., Eschenbruch C., Zink-Wohlfart C., et al. Effects of inhaled nitric oxide and aerosolized iloprost in pulmonary veno-occlusive disease. Respir Med 93 1 (1999) 62-64
66. Jais X., Launay D., Yaici A., et al. Immunosuppressive therapy in lupus- and mixed connective tissue disease-associated pulmonary arterial hypertension: a retrospective analysis of twenty-three cases. Arthritis Rheum 58 2 (2008) 521-531
67. Sanchez O., Sitbon O., Jais X., Simonneau G., and Humbert M. Immunosuppressive therapy in connective tissue diseases-associated pulmonary arterial hypertension. Chest 130 1 (2006) 182-189
68. Cohn R.C., Wong R., Spohn W.A., and Komer M. Death due to diffuse alveolar hemorrhage in a child with pulmonary veno-occlusive disease. Chest 100 5 (1991) 1456-1458
69. Justo R.N., Dare A.J., Whight C.M., and Radford D.J. Pulmonary veno-occlusive disease: diagnosis during life in four patients. Arch Dis Child 68 1 (1993) 97-100
70. Izbicki G., Shitrit D., Schechtman I., et al. Recurrence of pulmonary veno-occlusive disease after heart-lung transplantation. J Heart Lung Transplant 24 5 (2005) 635-637
71. O'Callaghan D., and Gaine S.P. Combination therapy and new types of agents for pulmonary arterial hypertension. Clin Chest Med 28 1 (2007) 169-185